Wednesday, February 8, 2012 Last update: 10:34 PM
The Best of U.S. Company Technology News
Now being accepted at FreshNews.com. See our complete guidelines.
Trade Events
Salix Pharmaceuticals, Ltd.
News articles for Salix Pharmaceuticals, Ltd.:
Tuesday, December 20, 2011
- Salix Pharmaceuticals Completes Acquisition of Oceana TherapeuticsSalix Pharmaceuticals, Ltd. (NASDAQ:SLXP) and Oceana Therapeutics, LLC today closed a transaction whereby Salix acquired all of the outstanding stock of Oceana Therapeutics, Inc., a privately-held global provider ... read moreSalix and Progenics Announce Positive Highly Statistically Significant Results of Oral Methylnaltrexone for Phase 3 Trial in Chronic, Non-Cancer Pain Subjects with Opioid-Induced ConstipationSalix Pharmaceuticals, Ltd. (NASDAQ:SLXP) and Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) today announced the successful outcome of the Phase 3 trial to evaluate the efficacy and safety of oral methylnaltrexone ... read more
Wednesday, December 14, 2011
- Salix Pharmaceuticals Announces NDA Submission for Crofelemer for the Treatment of HIV-Associated DiarrheaSalix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company has submitted to the U.S. Food and Drug Administration (FDA) a New Drug Application (NDA) for Crofelemer for the ... read more
Wednesday, November 16, 2011
- FDA Advisory Committee Supports Proposed Clinical Trial Design to Evaluate Repeat Treatment Cycles of XIFAXAN® for Irritable Bowel Syndrome with DiarrheaSalix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Gastrointestinal Drugs Advisory Committee of the FDA supports the Salix/FDA developed proposed design of a clinical trial to evaluate the ... read more
Thursday, November 3, 2011
- Salix Pharmaceuticals to Present at Two Investment Conferences in NovemberSalix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at two health care investment conferences during November 2011. Information regarding these conferences is provided below: ... read more
Tuesday, October 25, 2011
- Salix Pharmaceuticals Announces 3Q2011 Financial Results Conference Call and WebcastSalix Pharmaceuticals, Ltd. (NASDAQ: SLXP) today announced that the Company will report third quarter 2011 financial results following the close of the U.S. financial markets on Tuesday, November ... read more
Wednesday, August 31, 2011
- Salix Pharmaceuticals to Present at Three Investment Conferences in SeptemberSalix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at three health care investment conferences during September 2011. Information of these conferences is provided below: ... read more
Tuesday, August 30, 2011
- Progenics and Salix Announce FDA Acceptance of sNDA Filing for RELISTOR® in Patients with Non-Cancer PainProgenics Pharmaceuticals, Inc. (NASDAQ:PGNX) and Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug ... read more